Pharma Pharmaceutical Industries
Pharma Pharmaceutical Industries (PPI) is a Saudi-based pharmaceutical manufacturer and contract development/ manufacturing organization operating an R&D hub and a cGMP production site in Riyadh. The company provides end-to-end services that include research and development, analytical and stability testing, biologics and generic drug manufacturing, regulatory dossier preparation and eCTD submissions, technology transfer, warehousing and logistics, and pharmacovigilance support. PPI reports regional partnerships and holds regulatory GMP certifications.
Industries
Nr. of Employees
medium (51-250)
Pharma Pharmaceutical Industries
Office 601, Sircon Building No15, Riyadh, KSA; Manufacturing plant: 2nd Industrial City zone, Riyadh, KSA
Products
Insulin glargine (long-acting insulin)
Long-acting insulin formulation available in vial, disposable pen and cartridge formats for diabetes management.
Insulin formulations (mix, regular, NPH)
Range of insulin products including intermediate- and short-acting formulations for glycemic control.
Monoclonal antibodies and oncology biologics (e.g., anti-TNF, anti-VEGF)
Parenteral biologic therapies used in oncology, autoimmune and inflammatory conditions delivered as injectable formulations.
Small-molecule generics (cardiovascular, anticoagulants, antifungals, antibiotics, etc.)
A portfolio of niche and first-to-file generic oral and injectable products across multiple therapeutic areas.
Insulin glargine (long-acting insulin)
Long-acting insulin formulation available in vial, disposable pen and cartridge formats for diabetes management.
Insulin formulations (mix, regular, NPH)
Range of insulin products including intermediate- and short-acting formulations for glycemic control.
Monoclonal antibodies and oncology biologics (e.g., anti-TNF, anti-VEGF)
Parenteral biologic therapies used in oncology, autoimmune and inflammatory conditions delivered as injectable formulations.
Small-molecule generics (cardiovascular, anticoagulants, antifungals, antibiotics, etc.)
A portfolio of niche and first-to-file generic oral and injectable products across multiple therapeutic areas.
Services
End-to-end contract manufacturing including industrial-scale trial batches, full production runs and technology transfer for third-party products.
Dossier preparation, CTD/eCTD formatting and submission support for regulated and semi-regulated markets; assistance with firm and product registration.
QC testing and quality management systems aligned with cGMP and local regulatory standards, including analytical method validation and product release testing.
Pre-clinical studies, formulation development, stability studies, analytical development and coordination of bioequivalence studies via CROs.
Storage and distribution services integrated with manufacturing and packaging operations.
Dedicated channel for receiving product inquiries and adverse event reports to support safety monitoring.
End-to-end contract manufacturing including industrial-scale trial batches, full production runs and technology transfer for third-party products.
Dossier preparation, CTD/eCTD formatting and submission support for regulated and semi-regulated markets; assistance with firm and product registration.
QC testing and quality management systems aligned with cGMP and local regulatory standards, including analytical method validation and product release testing.
Pre-clinical studies, formulation development, stability studies, analytical development and coordination of bioequivalence studies via CROs.
Storage and distribution services integrated with manufacturing and packaging operations.
Dedicated channel for receiving product inquiries and adverse event reports to support safety monitoring.
Expertise Areas
- Contract manufacturing (CMO) and scale-up
- Biologics and biosimilars manufacturing
- Generic formulation development (oral solids, injectables, orodispersible films)
- Analytical method development and validation
Key Technologies
- cGMP manufacturing systems
- Analytical method development and stability testing
- Biologics production and sterile fill/finish
- Cell culture techniques
News & Updates
Overview article describing sector trends (biologics, single-use systems, AI and automation) and the company's role in biopharmaceutical manufacturing.
GMP certification from the national regulatory authority (certificate number reported).
GCC-region GMP certification reported for the manufacturing site.
Overview article describing sector trends (biologics, single-use systems, AI and automation) and the company's role in biopharmaceutical manufacturing.
GMP certification from the national regulatory authority (certificate number reported).
GCC-region GMP certification reported for the manufacturing site.